Video

What keeps you up at night in ophthalmology: Part II

Author(s):

Alex Delaney-Gesing
Conferences|GLAUCOMA 360

Pharmaceutical representatives share what keeps them up at night within the ophthalmic space.


In this second video installment, pharmaceutical representatives share what keeps them up at night within the ophthalmic and glaucoma space while attending the 2020 Glaucoma 360 meeting in San Francisco, California.

Featured: Chris Adams, Diopter Corp (CEO); Daria Lemann-Blumenthal, BELKIN Laser Ltd (CEO); Victor Chan, MB, MS, director of U.S. Surgical Device Commercial Marketing (Santen, Inc); Ramin Valian, vice president of International Glaucoma, Reimbursement and Pipeline (Allergan).

Watch the first installment here

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(mage credit: Ophthalmology Times) S. Robert Levine, MD, on the DRD Cure Accelerator: A global moonshot for retinal disease
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
Related Content
(Image credit: Wills Eye Hospital) Wills Eye Hospital names Julia A. Haller, MD, as new chief executive officer
July 31st 2025

Wills Eye Hospital names Julia A. Haller, MD, as new chief executive officer

3 Things You Should Know About the GA Pipeline
July 31st 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

(Image credit: AdobeStock/iQoncept) Q&A: Jeffrey L. Goldberg, MD, PhD, on the rise of clinical trials centers of excellence
July 31st 2025

Q&A: Jeffrey L. Goldberg, MD, PhD, on the rise of clinical trials centers of excellence

Patient-Centered Treatment Strategies in the Management of nAMD and DME
July 31st 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

New law broadens prescribing and procedure rights for Minnesota optometrists
July 31st 2025

New law broadens prescribing and procedure rights for Minnesota optometrists

Nicox and Kowa sign agreement for exclusive rights to glaucoma treatment NCX 470
July 31st 2025

Nicox and Kowa sign agreement for exclusive rights to glaucoma treatment NCX 470

© 2025 MJH Life Sciences

All rights reserved.